Simplex Trading’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-18
Closed -$1K 10134
2023
Q1
$1K Sell
18
-16
-47% -$1.37K ﹤0.01% 8813
2022
Q4
$1K Sell
34
-12
-26% -$664 ﹤0.01% 8968
2022
Q3
$2K Sell
46
-389
-89% -$22.8K ﹤0.01% 9403
2022
Q2
$22K Buy
435
+29
+7% +$1.74K ﹤0.01% 7509
2022
Q1
$22K Buy
406
+355
+696% +$21.5K ﹤0.01% 8169
2021
Q4
$3K Sell
51
-175
-77% -$15.2K ﹤0.01% 9896
2021
Q3
$25K Buy
226
+3
+1% +$320 ﹤0.01% 8253
2021
Q2
$25K Buy
223
+216
+3,086% +$25.1K ﹤0.01% 8405
2021
Q1
$88K Buy
7
+6
+600% +$839 ﹤0.01% 5923
2020
Q4
$14K Buy
+1
New +$118 ﹤0.01% 7220
2020
Q3
Hold
0
7234

Other funds holding QNTM

Simplex Trading's QNTM Position: Q3 2024 in Review

Simplex Trading sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q3 2024, closing a stake of 13 shares.

Simplex Trading first reported a position in QNTM in Q3 2020 and held it in 7 quarters. The position peaked at $27K in Q2 2021. 12 funds tracked by Wall St. Rank hold QNTM as of Q3 2024.

  • Simplex Trading reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q3 2024 after selling out during the quarter.
  • Simplex Trading sold 13 Quantum Biopharma Class B Subordinate Voting Shares shares in Q3 2024.
  • Simplex Trading first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q3 2020 and held it in 7 quarters.
  • Simplex Trading's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $27K in Q2 2021.
  • 12 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q3 2024.

Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.